39
Views
41
CrossRef citations to date
0
Altmetric
Research Article

Control of In Vivo Fate of Albumin Derivatives Utilizing Combined Chemical Modification

, , , , , & show all
Pages 157-165 | Received 19 Jan 1993, Accepted 03 Dec 1993, Published online: 20 Oct 2008

References

  • G. Ashwell, A. Morell. (1974). The role of surface carbohydrates in the hepatic recognition and transport of circulating glycoproteins Adv. Enzymol. 47:99–128.
  • B. Brown, R. Comeau, P. Jones, F. Liberatone, W. Neacy, H. Sands, N. Gallagher. (1987). Pharmacokinetics of the monoclonal antibody B72.3 and its fragments labelled with either 125I or 111In Cancer Res. 47:1149–1154.
  • J. Dohlman, D. Pillion, L. Rokeach, M. Ramprasad. (1991). Identification of macrophage cellsurface binding sites for cationized bovine serum albumin Biochem. Biophys. Res. Commun. 181:787–796.
  • L. Fiume, A. Mattiolo, C. Buci, G. Spinosa, Th. Wieland. (1982). Conjugates of adenosine9arabinofuranoside monophosphate araAMP with lactosaminated homologous albumin are not immunogenic in the mouse Experientia 38:1087–1089.
  • L. Fiume, B. Bassi, C. Buci, A. Mattiolo, G. Spinosa. (1986). Drug targeting in antiviral chemotherapy: A chemically stable conjugate of 9Darabinofuranosyladenosine5'monophosphate with lactosaminated albumin accomplishes a selective delivery of the drug to liver cells Biochem. Pharmacol. 35:967–972.
  • F. Fuertges, A. Abuchowski. (1990). The clinical efficacy of polyethylene glycolmodified proteins J. Controlled Release 11:139–148.
  • T. Fujita, Y. Yasuda, Y. Takakura, M. Hashida, H. Sezaki. (1990). Alteration of biopharmaceutical properties of drug by their conjugation with water soluble macromolecules: uricasedextran conjugates J. Controlled Release 11:149–154.
  • T. Fujita, Y. Yasuda, Y. Takakura, M. Hashida, H. Sezaki. (1991). Tissue distribution of 111Inlabelled uricase conjugates with charged dextrans and polyethylene glycol J. PharmacobioDyn. 14:623–629.
  • T. Fujita, M. Nishikawa, C. Tamaki, Y. Takakura, M. Hashida, H. Sezaki. (1992a). Targeted delivery of human recombinant superoxide dismutase by chemical modification with mono and polysaccharide derivatives J. Pharmacol. Exp. Ther. 263:971–978.
  • T. Fujita, H. Furitsu, M. Nishikawa, Y. Takakura, H. Sezaki, M. Hashida. (1992b). Therapeutic effects of superoxide dismutase derivatives modified with mono or polysaccharides on hepatic injury induced by ischemia/reperfusion Biochem. Biophys. Res. Commun. 189:191–196.
  • G. Gray. (1974). The direct coupling of oligosaccharides to proteins and derivatized gels Arch. Biochem. Biophys. 163:426–428.
  • A. Habeeb. (1966). Determination of free amino groups in proteins by trinitrobenzensulfonic acid Anal. Biochem. 14:328–336.
  • D. Hnatowich, W. Layne, R. Childs. (1982). The preparation and labelling DTPAcoupled albumin Int. J. Appl. Radiat. Isot. 12:327–332.
  • N. Katre, M. Knauf, W. Laird. (1987). Chemical modification of recombinant interleukin2 by polyethylene glycol increases its potency in the murine Meth A sarcoma model Proc. Natl. Acad. Sci. USA 84:1487–1491.
  • U. Laemmli. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227:680–685.
  • Y. Lee, C. Stowell, M. Krantz. (1976). 2Imino2methoxyethyl 1thioglycosides: New reagents for attaching sugars to proteins Biochemistry 15:3956–3963.
  • O. Lowry, N. Rosebrough, A. Farr, R. Randall. (1951). Protein measurement with the folin phenol reagent J. Biol. Chem. 193:265–275.
  • S. Magnusson, T. Berg. (1989). Extremely rapid endocytosis, mediated by the mannose receptor of sinusoidal endothelial rat liver cells Biochem. J. 257:651–656.
  • A. Matsushima, H. Nishimura, Y. Ashihara, Y. Yokota, Y. Inada. (1980). Modification of E. coli asparaginase with 2, 4 bisOmethoxypolyethylene glycol6chlorostriazine activated PEG2: Disappearance of binding activity towards antiserum and retention of enzymatic activity Chem. Lett. 7:773–776.
  • D. Meijer, P. Sluijs. (1989). Covalent and noncovalent protein binding of drugs: Implications for hepatic clearance, storage, and cellspecific drug delivery Pharm. Res. 6:105–118.
  • K. Mihara, M. Mori, T. Hojo, Y. Takakura, H. Sezaki, M. Hashida. (1993). Disposition characteristics of model macromolecules in the perfused rat kidney Biol. Pharm. Bull. 16:158–162.
  • K. Nishida, K. Mihara, T. Takino, S. Nakane, Y. Takahara, M. Hashida, H. Sezaki. (1991a). Hepatic disposition characteristics of electrically charged macromolecules in rat in vivo and in the perfused liver Pharm. Res. 8:437–444.
  • K. Nishida, Y. Eguchi, T. Takino, Y. Takakura, M. Hashida, H. Sezaki. (1991b). Hepatic disposition characteristics of 111Inlabelled lactosaminated bovine serum albumin in rats Pharm. Res. 8:1253–1257.
  • M. Nishikawa, Y. Ohtsubo, J. Ohno, T. Fujita, Y. Koyama, F. Yamashita, M. Hashida, H. Sezaki. (1992). Pharmacokinetics of receptormediated endocytosis of glycosylated albumin in mice Int. J. Pharmaceut. 85:75–85.
  • A. Noguchi, T. Takahashi, T. Yamaguchi, K. Kitamura, Y. Takakura, M. Hashida, H. Sezaki. (1991). Tumor localization and in vivo antitumor activity of the immunoconjugate composed of antihuman colon cancer monoclonal antibody and mitomycin Cdextran conjugate Jpn. J. Cancer Res. 82:219–226.
  • W. Pardridge, A. Kumagai, J. Eisenberg. (1987). Chimeric peptides as a vehicle for peptide pharmacokinetical delivery through the bloodbrain barrier Biochem. Biophys. Res. Commun. 146:307–313.
  • C. Roos, S. Matsumoto, Y. Takakura, M. Hashida, H. Sezaki. (1984). Physicochemical and antitumor characteristics of some polyamino acid prodrug of mitomycin C Int. J. Pharmaceut. 22:75–87.
  • L. Roseng, H. Tolleshaug, T. Berg. (1992). Uptake, intracellular transport, and degradation of polyethylene glycolmodified asialofetuin in hepatocytes J. Biol. Chem. 267:22987–22993.
  • H. Sezaki, Y. Takakura, M. Hashida. (1989). Soluble macromolecular carriers for the delivery of antitumor drugs Adv. Drug Delivery Rev. 3:247–266.
  • Y. Takakura, Y. Kaneko, T. Fujita, M. Hashida, H. Maeda, H. Sezaki. (1989a). Control of pharmaceutical properties of soybean trypsin inhibitor by conjugation with dextran I: Synthesis and characterization J. Pharm. Sci. 74:117–121.
  • Y. Takakura, T. Fujita, M. Hashida, H. Maeda, H. Sezaki. (1989b). Control of pharaceutical properties of soybean trypsin inhibitor by conjugation with dextran II: Biopharmaceutical and pharmacological properties J. Pharm. Sci. 74:219–222.
  • Y. Takakura, T. Fujita, M. Hashida, H. Sezaki. (1990). Disposition characteristics of macromolecules in tumorbearing mice Pharm. Res. 7:339–346.
  • D. Triguero, J. Buciak, J. Yang, W. Pardridge. (1989). Bloodbrain barrier transport of cationized immunoglobulin G: Enhanced delivery compared to native protein Proc. Natl. Acad. Sci. USA 86:4761–4765.
  • D. Triguero, J. Buciak, W. Pardridge. (1991). Cationization of immunoglobulin G results in enhanced organ uptake of the protein after intravenous administration in rats and primate J. Pharmacol. Exp. Ther. 258:186–192.
  • K. Yamaoka, Y. Tanigawara, H. Tanaka, Y. Uno. (1981). A pharmacokinetic analysis program MULTI for microcomputer J. PharmacobioDyn. 4:879–885.
  • Y. Yasuda, T. Fujita, Y. Takakura, M. Hashida, H. Sezaki. (1990). Biochemical and biopharmaceutical properties of macromolecular conjugate of uricase with dextran and polyethylene glycol Chem. Pharm. Bull. 38:2053–2056.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.